A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008742/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy of ustekinumab in participants with
active systemic lupus erythematosus (SLE) who have not adequately responded to one or more
standard of care treatments.
提供机构：
Vivli
创建时间：
2023-01-19
